Oncology Institute (TOIIW) Interest Expenses (2021 - 2026)

Oncology Institute (TOIIW) has reported Interest Expenses for 6 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.

• Interest Expenses for Q1 2026 came in at $1.9 million, down 65.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.6 million (down 31.05% YoY), and the FY2025 annual result was $11.3 million, up 50.43% from the prior year.
• Interest Expenses was $1.9 million for Q1 2026 at Oncology Institute, up from $1.9 million in the prior quarter.
• Over five years, Interest Expenses peaked at $5.6 million in Q1 2025 and troughed at $61000.0 in Q2 2022.
• Average Interest Expenses over 5 years is $1.9 million, with a median of $1.9 million recorded in 2025.
• Year-over-year, Interest Expenses jumped 2585.25% in 2023 and sank 65.28% in 2026.
• Over 5 years, Interest Expenses stood at $61000.0 in 2022, then surged by 3081.97% to $1.9 million in 2023, then slumped by 39.82% to $1.2 million in 2024, then surged by 64.04% to $1.9 million in 2025, then increased by 0.94% to $1.9 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $1.9 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.